Search

everythinglearnresearchcommunity

for

Search:↓

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

Stem cells play a key role in nonmelanoma skin cancers, with different origins and genetic changes linked to basal and squamous cell carcinomas.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Revertant cell therapy shows promise for treating type XVII collagen deficiency, but better cell selection methods are needed.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

Vav2 and Vav3 proteins help control skin stem cell numbers and activity in both healthy and cancerous cells.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Rat hair follicle bulge cells can become nerve and glial cells, showing potential for neuroprotection.

Valproic acid and crocin together boost cell growth and may help treat nerve injuries.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

Activated protein C helps protect mice from radiation damage.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

The treatment was not recommended due to limited effectiveness and significant side effects.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Aged corneal cells can revert to a stem-like state to help repair tissue.

Basal cell carcinomas need extra mutations to grow from small to large tumors.

Spiny mice have resilient, large mitochondria that help them regenerate tissue.

Cepharanthine shows promise as a natural anticancer treatment.

Increased ODC expression makes normally tumor-resistant mice more prone to tumor development.

β-Catenin signaling is involved in brain cell growth after injury and could be a therapy target.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

A gene deletion causes the "hairless" trait in Iffa Credo rats.

GRHL3 is important for controlling gene activity in skin cells during different stages of their development.